Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyridoxal phosphatase is an enzyme that catalyzes the hydrolysis of pyridoxal 5′‑phosphate (PLP), the active form of vitamin B6, into pyridoxal and inorganic phosphate. It belongs to the family of hydrolases, specifically those acting on phosphoric monoester bonds. The systematic name for this enzyme is pyridoxal‑5′‑phosphate phosphohydrolase. It plays a crucial role in vitamin B6 metabolism by regulating cellular levels of PLP, which serves as a coenzyme in numerous enzymatic reactions essential for amino acid metabolism and other biosynthetic processes. Several alternative names are used for this enzyme, including PLP phosphatase and vitamin B6-phosphatase. Structural studies have revealed multiple solved structures for this class of enzymes[1]. There are no widely recognized drugs that directly target or inhibit pyridoxal phosphatase in clinical use or development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyridoxal phosphatase.